Multivitamins and infections
This article was originally published in The Tan Sheet
"Evidence for routine use of multivitamin and mineral supplements to reduce infections in elderly people is weak and conflicting," Alia El-Kadiki, University of Leicester, England, et al., report in the April 16 British Medical Journal. The authors conducted a meta-analysis of eight studies collected from Medline and other databases that evaluated the effect of multivitamins on infections in the elderly. The assessment focused on the mean difference in number of days spent with infection, the odds rate of at least one infection in the study period and the incidence rate ratio for the difference in infection rates. Three of the eight studies showed multivitamin use reduced the mean annual number of days spent with infection by 17.5, the authors note...
You may also be interested in...
EU Regulatory Roundup, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty
Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.
Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.
Fresenius Kabi and Vifor Pharma have agreed to create a joint venture in China for intravenous iron products.